Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities.

Shan D, Song J, Ren Y, Zhang Y, Ba Y, Luo P, Cheng Q, Xu H, Weng S, Zuo A, Liu S, Han X, Deng J, Liu Z

Open source

DOI
10.1002/cac2.70005
Published
2025 May
Container
Cancer communications (London, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cac2.70005,
  title = {Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities.},
  author = {Shan D and Song J and Ren Y and Zhang Y and Ba Y and Luo P and Cheng Q and Xu H and Weng S and Zuo A and Liu S and Han X and Deng J and Liu Z},
  year = {2025},
  journal = {Cancer communications (London, England)},
  doi = {10.1002/cac2.70005},
  url = {https://doi.org/10.1002/cac2.70005}
}

RIS

TY  - JOUR
TI  - Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities.
AU  - Shan D
AU  - Song J
AU  - Ren Y
AU  - Zhang Y
AU  - Ba Y
AU  - Luo P
AU  - Cheng Q
AU  - Xu H
AU  - Weng S
AU  - Zuo A
AU  - Liu S
AU  - Han X
AU  - Deng J
AU  - Liu Z
PY  - 2025
JO  - Cancer communications (London, England)
DO  - 10.1002/cac2.70005
UR  - https://doi.org/10.1002/cac2.70005
ER  - 

APA

D, S., J, S., Y, R., Y, Z., Y, B., P, L., Q, C., H, X., S, W., A, Z., S, L., X, H., J, D., & Z, L. (2025). Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities.. Cancer communications (London, England). https://doi.org/10.1002/cac2.70005

Source records